Skip to main content
Signal8

ORLOFF JOHN J

SEC insider (Form 3/4/5 filer). CIK 0001643941. Director at Zenas BioPharma, Inc. (ZBIO). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in WALTHAM, MA.

Companies ORLOFF JOHN J has filed insider reports for

  • Zenas BioPharma, Inc. (ZBIO): Director
ORLOFF JOHN J profile photo

ORLOFF JOHN J

CIK: 0001643941

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Zenas BioPharma, Inc. logo
ZBIO

Zenas BioPharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Jun 15, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    18.5K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Jun 10, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    18.5K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Sep 12, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    18.5K shares-

1-3 of 3